Breast Cancer and Lymph nodes?? Posted by admin on June 20th, 2011 Do you find what you need? Look here! Breast Cancer and Lymph nodes??My aunt has Breast cancer (Aggressive) and had a double Masectomy but the doctors have found that 2 or 3 of the lymph nodes were tested positive for cancer. Is that [...]
Fast-charging an EV isn’t new in itself, but deciding on a standard for it is. Which is why we’re glad to hear that Audi, BMW, Chrysler, Daimler, Ford, GM, Porsche and Volkswagen have all agreed to a common format for their EV charging ports, the not-very-elegantly-titled DC Fast Charging with a Combined Charging System. Together, [...]
I never LOVED my first job however it taught me so much about the importance of work and money management. It also taught me that I wanted to get an education so that I never had to work there ever again! Thanks Dad Follow me! Facebook: www.facebook.com Twitter: twitter.com SUBSCRIBE to THEMOMSVIEW www.youtube.com SUBSCRIBE to [...]
Pages: ?256 Genre: Adult/Travel Memoir Date Published: May 25, 2011 Obtained through TLC Book Tours My Rating: 4 out of 5 stars Goodreads says, “Spanning 15 years of travel, beginning when she is a sophomore in college,Wanderlust?documents Elisabeth Eaves?s insatiable hunger for the rush of the unfamiliar and the experience of encountering new people and [...]
THURSDAY, Oct. 6 (HealthDay News) — New research suggests certain long-term psychotherapies may do a better job than an antidepressant in preventing post-traumatic stress disorder (PTSD) following a traumatic event. The Israeli research team also found that delaying treatment for PTSD didn’t seem to boost a person’s risk of chronic symptoms. “A delayed intervention is [...]
This blog tells the story of my journey in breast cancer prevention after recovering from a third breast cancer and my discovery of permaculture on this journey.
There is so much good advice out there on breast cancer prevention including that from the the Mayo Clinic which includes developing healthy habits such as limiting the amount of alcohol you drink, staying physically active, maintaining a healthy weight, breast feeding and discontinuing hormone therapy.
All of these with the exception of breast feeding as I was unable to have children I was trying to put into practice when a third small breast cancer began.
The last piece of advice from the Mayo Clinic is to avoid exposure to environmental pollutants. They state some research suggests a link between breast cancer and exposure to the polycyclic aromatic hydrocarbons found in vehicle exhaust and air pollution.
My instinct was that the issue of environmental pollutants is much more complex than this and I decided to sell my apartment where to my knowledge five cases of cancer and three deaths have occurred in a space of a few years and find a new way to live.
Near my new house a community garden had just opened and I discovered at their workshops the relationship between healthy soil and healthy food.
With the knowledge gained at the community garden I attempted my dream of beginning my own sustainable home garden.
I sometimes think I am a slow learner for it was only much later I began to understand the nature and importance of permaculture.
Gold Coast Permaculture and its many powerful workshops really opened my eyes to a new way of both growing and eating food. It was and is also exciting to find so many other people looking for positive answers to old ways that cannot sustain quality life on this planet.
From a difficult time I had discovered permaculture, a new and healthy way of living for our planet and its people.
This post is part of Metamorphosis Monday and Show Off Your Cottage Monday.
AUSTIN, Texas (Reuters) ? Former Miss Venezuela Eva Ekvall died in Houston on Saturday after losing her battle with breast cancer, according to the Venezuelan TV news network Globovision. She was 28.
The former beauty queen had worked to promote cancer awareness since being diagnosed in 2010.
The hospital in Houston where she reportedly passed away, and the funeral home there where her body was taken declined to comment on news of her death.
Ekvall won the Miss Venezuela title in 2000 and was a third runner-up for Miss Universe in 2001. She also worked as an actress and television anchor.
Although known for her beauty, Ekvall was depicted bald and without makeup in her book Fuera de Foco (Out of Focus) released this year, which chronicled her fight with breast cancer. Photographer Roberto Mata showed the beauty queen throughout her cancer treatment and as her illness regressed. She wrote the text of the book.
SenosAyuda, a Caracas-based breast cancer awareness organization, said in a tribute on its website that Ekvall’s legacy will pave the way for thousands of Venezuelan women.
“Thank you for so much in so little time,” the tribute said in Spanish.
Ekvall is survived by her husband, her daughter, her parents and her brother, according to SenosAyuda.
(Reporting by Erin Mulvaney. Editing by Corrie MacLaggan and Greg McCune).
Public release date: 31-Oct-2011 [ | E-mail | Share ]
Contact: Kim Thurler kim.thurler@tufts.edu 617-627-3175 Tufts University
Cross-disciplinary Tufts team to use $6.6 Million award to develop ultra-sensitive ways to detect, treat disease at single-cell, single-molecule levels
BOSTON and MEDFORD/SOMERVILLE, Mass. — A team of scientists at Tufts University will develop ultra-sensitive techniques at the single-molecule and single-cell levels designed to detect breast cancer earlier, and treat it with greater precision, through a $6.6 million Innovator Award from the Department of Defense Breast Cancer Research Program made to Tufts chemist David R. Walt, Ph.D.
The Innovator Awards provide “individuals who have a history of creativity, innovative work, and leadership with the funding and freedom to pursue their most novel, visionary, high-risk ideas that could ultimately lead to the eradication of breast cancer.”
Principal Investigator Walt, who is Robinson Professor of Chemistry at Tufts’ School of Arts and Sciences and a Howard Hughes Medical Institute Professor, applies micro- and nanotechnology to urgent biological problems. Technologies that have come out of his laboratory include DNA microarrays, sequencing methods, medical diagnostic methods, and basic biochemistry research. He is credited with the first documented use of the word “microarray” in the scientific literature.
Collaborating with Walt are three Tufts specialists in breast cancer: Rachel Buchsbaum, M.D., the Diane Connolly-Zaniboni Scholar in Breast Cancer Research in the Molecular Oncology Research Institute at Tufts Medical Center, associate professor at Tufts University School of Medicine, and a breast oncologist and researcher on molecular mechanisms of metastasis and the cancer microenvironment; Charlotte Kuperwasser, Ph.D., associate professor at Tufts University School of Medicine and an expert on stem cell and tissue regulation of the molecular pathways of breast cancer progression; and Gail Sonenshein, Ph.D., professor at Tufts University School of Medicine, internationally known for her work in molecular signaling mechanisms in breast cancer. Buchsbaum, Kuperwasser and Sonenshein are also program faculty at the Sackler School of Graduate Biomedical Sciences at Tufts.
In addition, University of Washington chemist Daniel T. Chiu, Ph.D., a leader in microfluidics, will collaborate with the team.
Uncovering Biomarkers That Diagnose and Predict More Accurately
“While great progress has been made in early breast cancer detection and treatment, current methods cannot always determine if a tumor has metastasized or accurately characterize its cellular diversity. Nor do we understand how to distinguish those early breast cancers that are potentially lethal from breast cancers that are unlikely to recur or spread after initial treatment,” said Buchsbaum.
The research team will use Walt’s single-molecule techniques to uncover new biomarkers in the blood that they hope will have the specificity needed to accurately screen for breast cancer and to diagnose and predict the outcome of breast cancer. They will also characterize breast cancer biopsy samples with single-cell resolution to discover the nature of these complex cell populations so that more precise therapies can be devised.
“Our hope is to detect cancer-relevant biomarkers that would enable breast cancer screening to convert from mammography to a simple blood test,” said Walt. “Identification of such biomarkers would represent a major clinical advance.”
“By developing more sensitive and biologically precise tools for detecting breast cancer, patients can be diagnosed earlier in the disease process and the tumors better characterized. We hope this research will translate to more targeted therapeutic approaches, with higher efficacy and fewer side effects,” said Sonenshein.
###
Tufts University, located on three Massachusetts campuses in Boston, Medford/Somerville and Grafton, and in Talloires, France, is recognized among the premier research universities in the United States. Tufts enjoys a global reputation for academic excellence and for the preparation of students as leaders in a wide range of professions. A growing number of innovative teaching and research initiatives span all campuses, and collaboration among the faculty and students in the undergraduate, graduate and professional programs across the university is widely encouraged.
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Public release date: 31-Oct-2011 [ | E-mail | Share ]
Contact: Kim Thurler kim.thurler@tufts.edu 617-627-3175 Tufts University
Cross-disciplinary Tufts team to use $6.6 Million award to develop ultra-sensitive ways to detect, treat disease at single-cell, single-molecule levels
BOSTON and MEDFORD/SOMERVILLE, Mass. — A team of scientists at Tufts University will develop ultra-sensitive techniques at the single-molecule and single-cell levels designed to detect breast cancer earlier, and treat it with greater precision, through a $6.6 million Innovator Award from the Department of Defense Breast Cancer Research Program made to Tufts chemist David R. Walt, Ph.D.
The Innovator Awards provide “individuals who have a history of creativity, innovative work, and leadership with the funding and freedom to pursue their most novel, visionary, high-risk ideas that could ultimately lead to the eradication of breast cancer.”
Principal Investigator Walt, who is Robinson Professor of Chemistry at Tufts’ School of Arts and Sciences and a Howard Hughes Medical Institute Professor, applies micro- and nanotechnology to urgent biological problems. Technologies that have come out of his laboratory include DNA microarrays, sequencing methods, medical diagnostic methods, and basic biochemistry research. He is credited with the first documented use of the word “microarray” in the scientific literature.
Collaborating with Walt are three Tufts specialists in breast cancer: Rachel Buchsbaum, M.D., the Diane Connolly-Zaniboni Scholar in Breast Cancer Research in the Molecular Oncology Research Institute at Tufts Medical Center, associate professor at Tufts University School of Medicine, and a breast oncologist and researcher on molecular mechanisms of metastasis and the cancer microenvironment; Charlotte Kuperwasser, Ph.D., associate professor at Tufts University School of Medicine and an expert on stem cell and tissue regulation of the molecular pathways of breast cancer progression; and Gail Sonenshein, Ph.D., professor at Tufts University School of Medicine, internationally known for her work in molecular signaling mechanisms in breast cancer. Buchsbaum, Kuperwasser and Sonenshein are also program faculty at the Sackler School of Graduate Biomedical Sciences at Tufts.
In addition, University of Washington chemist Daniel T. Chiu, Ph.D., a leader in microfluidics, will collaborate with the team.
Uncovering Biomarkers That Diagnose and Predict More Accurately
“While great progress has been made in early breast cancer detection and treatment, current methods cannot always determine if a tumor has metastasized or accurately characterize its cellular diversity. Nor do we understand how to distinguish those early breast cancers that are potentially lethal from breast cancers that are unlikely to recur or spread after initial treatment,” said Buchsbaum.
The research team will use Walt’s single-molecule techniques to uncover new biomarkers in the blood that they hope will have the specificity needed to accurately screen for breast cancer and to diagnose and predict the outcome of breast cancer. They will also characterize breast cancer biopsy samples with single-cell resolution to discover the nature of these complex cell populations so that more precise therapies can be devised.
“Our hope is to detect cancer-relevant biomarkers that would enable breast cancer screening to convert from mammography to a simple blood test,” said Walt. “Identification of such biomarkers would represent a major clinical advance.”
“By developing more sensitive and biologically precise tools for detecting breast cancer, patients can be diagnosed earlier in the disease process and the tumors better characterized. We hope this research will translate to more targeted therapeutic approaches, with higher efficacy and fewer side effects,” said Sonenshein.
###
Tufts University, located on three Massachusetts campuses in Boston, Medford/Somerville and Grafton, and in Talloires, France, is recognized among the premier research universities in the United States. Tufts enjoys a global reputation for academic excellence and for the preparation of students as leaders in a wide range of professions. A growing number of innovative teaching and research initiatives span all campuses, and collaboration among the faculty and students in the undergraduate, graduate and professional programs across the university is widely encouraged.
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
BreastCancer and Lymph nodes??My aunt has Breast cancer (Aggressive) and had a double Masectomy but the doctors have found that 2 or 3 of the lymph nodes were tested positive for cancer. Is that good dose this mean proable death or can they be removed?? I?m a little confused. Please Help
-Just Dave So many new methods of treatment have come along in the last several years that there is no reason to say that death is probable. The lymph nodes can usually be removed, followed by either radiation therapy or chemotherapy. Most women who experience cancer and are treated go on to live for many years, and quite a large number actually go into remission. Remission is when all traces of the cancer are gone and healthy living is normal. There are many hospitals that offer support groups for cancer patients and for family and loved ones of ALL ages. Usually two separate groups. She can spend time with other women who have cancer and understand completely what she is feeling. YOU and your family can spend time with other families who have the same worries and fears. You can pour your heart out to others who know exactly how you feel and will try to help you learn and live with it. People who have cancer very often spend a lot of time worrying about the people they love, and not only their own problem with cancer. Talk to her. Tell her how you feel. Make her understand that you love her and are concerned, and that you don?t want to be left out of the conversations. Read articles about cancer, cancer treatment and coping with cancer. Most of all, don?t let cancer ruin your emotions or your aunts. Cancer certainly wakes us up from feeling that we are immortal. You feel like you are looking down the barrel of a gun. And you feel helpless, which is very sad, but very hard to ignore. The best thing you can do for yourself and your aunt is to take time to be with her. Be encouraging. Be loving. Be caring. Spend time talking about everything you both enjoy. Cancer is hard, but love makes it much easier.
-Denisedds You are not giving enough information to give you a decent answer. Her prognosis largely depends on the stage of her cancer and if her hormone receptors were positive or not. 2 or 3 lymph nodes were positive out of how many? Or was it a sentinel lymph node biopsy?
To answer you questions. This in itself does not mean death is probable or even likely. The positive lymph nodes were removed.
What do you think? Answer below!Breast Cancer Care Blog ? Breast Cancer Treatment Information and Pictures.
You might also like:
You can leave a response, or trackback from your own site.
Entries
My instinct was that the issue of environmental pollutants is much more complex than this and I decided to sell my apartment where to my knowledge five cases of cancer and three deaths have occurred in a space of a few years and find a new way to live.![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
Public release date: 31-Oct-2011
Share ]